PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis
Jun 1, 2021, 00:00
10.1016/j.jval.2021.04.800
https://www.valueinhealthjournal.com/article/S1098-3015(21)01017-2/fulltext
Title :
PND16 Socioeconomic Value of Ocrelizumab in the Treatment of Patients with Primary Progressive Multiple Sclerosis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(21)01017-2&doi=10.1016/j.jval.2021.04.800
First page :
Section Title :
Open access? :
No
Section Order :
10306